Soleus Capital Management’s NeoGenomics NEO Stock Holding History

Soleus Capital Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$146K	Sell	10,000 -165,000	-94%	-$1.59M	0.01%	97
2026 Q1	$1.3M	Sell	175,000 -252,504	-59%	-$2.66M	0.05%	82
2025 Q4	$5.03M	Buy	+427,504	New	+$4.61M	0.19%	67
2022 Q2	–	Sell	-460,000	Closed	-$5.59M	–	79
2022 Q1	$5.59M	Buy	+460,000	New	+$9.68M	0.72%	41
2021 Q4	–	Sell	-190,556	Closed	-$9.19M	–	83
2021 Q3	$9.19M	Sell	190,556 -161,451	-46%	-$7.47M	1.43%	21
2021 Q2	$15.9M	Buy	352,007 +306,056	+666%	+$13.6M	2.45%	11
2021 Q1	$2.22M	Hold	45,951	–	–	0.4%	49
2020 Q4	$2.47M	Buy	+45,951	New	+$2.08M	0.33%	32

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Soleus Capital Management's NEO Position: Q2 2026 in Review

Soleus Capital Management reduced its NeoGenomics (NEO) stake by 94% in Q2 2026, selling an estimated $1.59M and leaving 10,000 shares worth $146K. The position accounts for 0.01% of the portfolio, ranked #97.

Soleus Capital Management first reported a position in NEO in Q4 2020 and has held it in 8 quarters since. The position peaked at $15.9M in Q2 2021. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Soleus Capital Management held 10,000 shares of NeoGenomics worth $146K as of Q2 2026.
Soleus Capital Management sold 165,000 NeoGenomics shares in Q2 2026, an estimated $1.59M.
NeoGenomics made up 0.01% of Soleus Capital Management's portfolio in Q2 2026, its #97 holding.
Soleus Capital Management first reported a position in NeoGenomics in Q4 2020 and has held it in 8 quarters since.
Soleus Capital Management's NeoGenomics position peaked at $15.9M in Q2 2021.
267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.